The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Anticytokine treatment of established type II collagen-induced arthritis in DBA/1 mice: A comparative study using anti-TNFα, anti-IL-1α/β and IL-1Ra
Abstract
OBJECTIVE: To examine the role of tumor necrosis factor alpha (TNF alpha), interleukin-1 alpha (IL-1 alpha), and IL-1 beta in collagen-induced arthritis (CIA), immediately after onset and during the phase of established arthritis. METHODS: Male DBA/1 mice with collagen-induced arthritis were treated with antibodies against murine TNF alpha and IL-1 alpha/beta at different time points of the disease. IL-1 receptor antagonist (IL-1Ra) was administered using Alzet osmotic minipumps. The effect of anticytokine treatment was monitored by visual scoring. Histology and cytokine reverse transcription polymerase chain reaction (RT-PCR) analyses were performed at the end of the treatment period. RESULTS: Anti-TNF alpha treatment showed efficacy shortly after onset of the disease, but had little effect on fully established CIA. Histologic analysis after early treatment revealed that anti-TNF alpha significantly reduced joint pathology, as determined by infiltration of inflammatory cells and cartilage damage. Anti-IL-1 alpha/beta treatment ameliorated both early and full-blown CIA. This clear suppression of established arthritis was confirmed by administration of high doses of IL-1Ra. Dose-response experiments showed that a continuous supply of 1 mg/day was needed for optimal suppression. Histologic analysis showed markedly reduced cartilage destruction both in the knee and the ankle joints. Autoradiography demonstrated full recovery of chondrocyte synthetic function of articular cartilage. In addition, we found that the IL-1 beta isoform plays a dominant role in established CIA. Profound suppression of CIA was observed with anti-IL-1 beta, although elimination of both IL-1 alpha and IL-1 beta still gave better protection. Analysis of messenger RNA with RT-PCR revealed that IL-1 beta was highly upregulated in synovium and cartilage at late stages of CIA, whereas anti-IL-1 beta treatment markedly reduced IL-1 beta message in the synovium. CONCLUSION: The present study identified different TNF alpha/IL-1 dependencies in various stages of CIA and revealed that blocking of TNF alpha does not necessarily eliminate IL-1. Continuous, high doses of IL-1Ra are needed to block CIA.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
Chomczynski, P., & Sacchi, N. (1987) · Analytical Biochemistry · doi:10.1016/0003-2697(87)90021-2 · Cited by 46,426
Elliott, M. J., Maini, R. N., Feldmann, M., Kalden, J. R., Antoni, C., Smolen, J. S., Leeb, B., Breedveld, F. C., Macfarlane, J. D., Bijl, J. A., et al. (1994) · The Lancet · doi:10.1016/s0140-6736(94)90628-9 · Cited by 1,682
Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis.
Keffer, J., Probert, L., Cazlaris, H., Georgopoulos, S., Kaslaris, E., Kioussis, D., & Kollias, G. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb04978.x · Cited by 1,660
Quantitation of mRNA by the polymerase chain reaction.
Wang, A. M., Doyle, M. V., & Mark, D. F. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.24.9717 · Cited by 1,625
Autoimmunity to type II collagen an experimental model of arthritis.
Trentham, D. E., Townes, A. S., & Kang, A. H. (1977) · The Journal of experimental medicine · doi:10.1084/jem.146.3.857 · Cited by 1,603
Li, P., Allen, H., Banerjee, S., Franklin, S., Herzog, L., Johnston, C., McDowell, J., Paskind, M., Rodman, L., Salfeld, J., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90490-5 · Cited by 1,417
BRENNAN, F. (1989) · The Lancet · doi:10.1016/s0140-6736(89)90430-3 · Cited by 1,129
Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor α
Elliott, M. J., Maini, R. N., Feldmann, M., Long‐Fox, A., Charles, P., Katsikis, P., Brennan, F. M., Walker, J., Bijl, H., Ghrayeb, J., et al. (1993) · Arthritis & Rheumatism · doi:10.1002/art.1780361206 · Cited by 1,038
Immunisation against heterologous type II collagen induces arthritis in mice
Courtenay, J. S., Dallman, M. J., Dayan, A. D., Martin, A., & Mosedale, B. (1980) · Nature · doi:10.1038/283666a0 · Cited by 1,025
Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis.
Williams, R. O., Feldmann, M., & Maini, R. N. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.20.9784 · Cited by 989
Arend, W. P., & Dayer, J. (1995) · Arthritis & Rheumatism · doi:10.1002/art.1780380202 · Cited by 891
[2] Preparation and characterization of the different types of collagen
Miller, E. J., & Kent Rhodes, R. (1982) · Methods in Enzymology · doi:10.1016/0076-6879(82)82059-4 · Cited by 752
Tumour necrosis factor α stimulates resorption and inhibits synthesis of proteoglycan in cartilage
Saklatvala, J. (1986) · Nature · doi:10.1038/322547a0 · Cited by 745
Wooley, P. H., Luthra, H. S., Stuart, J. M., & David, C. S. (1981) · The Journal of experimental medicine · doi:10.1084/jem.154.3.688 · Cited by 687
Interleukin-1 Receptor Antagonist
Arend, W. P. (1993) · Advances in Immunology · doi:10.1016/s0065-2776(08)60535-0 · Cited by 671
Quantitative analysis of cytokine gene expression in rheumatoid arthritis.
Firestein, G. S., Alvaro-Gracia, J. M., & Maki, R. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.144.9.3347 · Cited by 598
Biological properties of recombinant human monocyte-derived interleukin 1 receptor antagonist.
Arend, W. P., Welgus, H. G., Thompson, R. C., & Eisenberg, S. P. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114622 · Cited by 581
Echtenacher, B., Falk, W., Männel, D. N., & Krammer, P. H. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.145.11.3762 · Cited by 433
Loo, F. A. J. V. D., Joosten, L. A. B., Van Lent, P. L. E. M., Arntz, O. J., & Van Den Berg, W. B. (1995) · Arthritis & Rheumatism · doi:10.1002/art.1780380204 · Cited by 380
Thorbecke, G. J., Shah, R., Leu, C. H., Kuruvilla, A. P., Hardison, A. M., & Palladino, M. A. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.16.7375 · Cited by 360
Wooley, P. H., Dutcher, J., Widmer, M. B., & Gillis, S. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.11.6602 · Cited by 293
Amelioration of established murine collagen-induced arthritis with anti-IL-1 treatment
VAN DEN BERG, W. B., JOOSTEN, L. A. B., HELSEN, M., & VAN DE LOO, F. A. J. (2008) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.1994.tb06517.x · Cited by 251
Henderson, B. E., & Pettipher, E. R. (1989) · PubMed Central · Cited by 245
Piguet, P. F., Grau, G. E., Vesin, C., Loetscher, H., Gentz, R., & Lesslauer, W. (1992) · PubMed Central · Cited by 232
RANKIN, E. C. C., CHOY, E. H. S., KASSIMOS, D., KINGSLEY, G. H., SOPWTTH, A. M., ISENBERG, D. A., & PANAYI, G. S. (1995) · Rheumatology · doi:10.1093/rheumatology/34.4.334 · Cited by 231
In vivo cytokine gene expression in T cell subsets of the autoimmune MRL/Mp‐lpr/lpr mouse
Murray, L. J., Lee, R., & Martens, C. (1990) · European Journal of Immunology · doi:10.1002/eji.1830200124 · Cited by 215
Wooley, P. H., Whalen, J. D., Chapman, D. L., Berger, A. E., Richard, K. A., Aspar, D. G., & Staite, N. D. (1993) · Arthritis & Rheumatism · doi:10.1002/art.1780360915 · Cited by 204
Villiger, P. M., Terkeltaub, R., & Lotz, M. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.149.2.722 · Cited by 194
Stuart, J. M., Townes, A. S., & Kang, A. H. (1982) · Journal of Clinical Investigation · doi:10.1172/jci110495 · Cited by 188
Probert, L., Plows, D., Kontogeorgos, G., & Kollias, G. A. (1995) · European Journal of Immunology · doi:10.1002/eji.1830250647 · Cited by 171
In vivo administration with IL-1 accelerates the development of collagen-induced arthritis in mice.
Hom, J. T., Bendele, A. M., & Carlson, D. G. (1988) · The Journal of Immunology · doi:10.4049/jimmunol.141.3.834 · Cited by 153
Nasrin, N., Ercolani, L., Denaro, M., Kong, X. F., Kang, I., & Alexander-Bridges, M. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.14.5273 · Cited by 148
Geiger, T. M., Towbin, H., Cosenti-Vargas, A., Zingel, O., Arnold, J., Rordorf, C. M., Glatt, M., & Vosbeck, K. (1993) · PubMed · Cited by 115
van de Loo, F. A. J., Arntz, O. J., Otterness, I. G., & van den Berg, W. B. (1992) · PubMed · Cited by 92
Superantigen can reactivate bacterial cell wall-induced arthritis
Schwab, J. H., Brown, R. R., Anderle, S. K., et al. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.150.9.4151 · Cited by 90
The role of cytokines and their inhibitors in arthritis
Dayer, J., & Fenner, H. (1992) · Baillière s Clinical Rheumatology · doi:10.1016/s0950-3579(05)80186-4 · Cited by 78
Chikanza, I. C., Roux‐Lombard, P., Dayer, J., & Panayi, G. S. (1995) · Arthritis & Rheumatism · doi:10.1002/art.1780380511 · Cited by 66
Lewthwaite, J. C., Blake, S. M., Hardingham, T., Pj, W., & Henderson, B. E. (1994) · PubMed · Cited by 56
van den Broek, M. F., van den Berg, W. B., van de Putte, L. B., & Severijnen, A. J. (1988) · PubMed · Cited by 48
van Osch, G. J. V. M., van der Kraan, P. M., & van den Berg, W. B. (1994) · Journal of Orthopaedic Research® · doi:10.1002/jor.1100120204 · Cited by 44
Antagonistic Effects of Endogenous and Exogenous Tgf-$sZ and Tnf on Auto-immune Diseases in Mice
Santambrogio, L., Hochwald, G. M., Leu, C. H., & Thorbecke, G. J. (1993) · Immunopharmacology and Immunotoxicology · doi:10.3109/08923979309035240 · Cited by 38
Chensue, S. W., Bienkowski, M., Eessalu, T. E., Warmington, K. S., Hershey, S. D., Lukacs, N. W., & Kunkel, S. L. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.7.3654 · Cited by 31
Maeda, T., Saikawa, I., Hotokebuchi, T., et al. (1994) · Arthritis & Rheumatism · doi:10.1002/art.1780370315 · Cited by 26
Cited by
Cytokine Pathways and Joint Inflammation in Rheumatoid Arthritis
Choy, E. H. S., & Panayi, G. S. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103223441207 · Cited by 2,249
Low-grade inflammation as a key mediator of the pathogenesis of osteoarthritis
Robinson, W. H., Lepus, C. M., Wang, Q., Raghu, H., Mao, R., Lindstrom, T. M., & Sokolove, J. (2016) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2016.136 · Cited by 1,438
Pelletier, J.-P., Martel-Pelletier, J., & Abramson, S. B. (2001) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200106)44:6<1237::aid-art214>3.0.co;2-f · Cited by 1,072
Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist
Bresnihan, B., Alvaro-Gracia, J. M., Cobby, M., Doherty, M., Domljan, Z., Emery, P., Nuki, G., Pavelka, K., Rau, R., Rozman, B., et al. (1998) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199812)41:12<2196::aid-art15>3.0.co;2-2 · Cited by 981
IL-1 pathways in inflammation and human diseases
Gabay, C., Lamacchia, C., & Palmer, G. (2010) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2010.4 · Cited by 897
Metadata
- Venue
- Arthritis & Rheumatism
- Publisher
- Wiley
- Published
- 2008-02
- Volume
- 58
- Issue
- S2
- Pages
- S110-S122
- ISSN
- 0004-3591 (ISSN-L)
- 1529-0131
- OpenAlex
- W2084030755
- Cited by
- 505
- References
- 43
- FWCI
- 18.21
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.